Breakthrough Partnership continues for three years
Last updated on: 04 March 2024
The Breakthrough Partnership will continue for three years until 2026. Initiated and funded by ViiV Healthcare Positive Action in 2020, the partnership aims to create sustainable change to end paediatric HIV in regions most urgent. As Aidsfonds we are exited to continue as partner in this ambitious collaboration together with EGPAF, PATA and UNICEF to continue our impactful work in Uganda, Nigeria and Mozambique.
The Breakthrough Partnership
The partnership strengthens collaborations between community, health facilities, government, health care providers and civil society, with communities at the centre, to prevent mother to child transmission and provide HIV treatment and care to reach all children living with HIV and their mothers in the community. Through this collaboration, the Breakthrough Partnership aims to end paediatric AIDS and HIV transmission by 2030
In three Breakthrough countries we work with our valuable community partners to implement the community-based paediatric HIV approach: Community Health Alliance Uganda (CHAU), the National Forum of People living with HIV and AIDS Networks Uganda (NAFOPHANU) and Health Need Uganda, with N’weti in Mozambique and with Society for Family Health in Nigeria.
The Paediatric HIV Breakthrough Partnership is an ambitious initiative committed to ending paediatric HIV in regions most urgent. It aims to strengthen collaboration between community, health facilities, government, health care providers and civil society, placing communities at the heart of the response. Aidsfonds, together with the Elisabeth Glaser Pediatric Foundation, PATA and UNICEF, collaborates in this partnership which was initiated and funded by ViiV Healthcare Positive Action.
Communities
Adolescent girls and young women, Children
The EU Steps Up for Global Health in Uncertain Times
The EU Steps Up for Global Health in Uncertain Times
Today, the European Commission announced its intention to pledge a total of €700 million overall for the 8th Global Fund’s replenishment, subject to the outcome of the upcoming Multiannual Financial Framework negotiations.
At a time when budgets are under strain, priorities are competing, and the world feels increasingly unstable, stepping up for people affected by HIV, TB and malaria around the world is very welcome and a clear sign of the EU’s ambition to lead on global health. This commitment will help save millions of lives and keep everyone safer, including in Europe. It will support Africa’s ability to lead on its own health priorities, and build resilience in places under severe stress. This includes countries affected by war, such as Ukraine, where the continuity of HIV and TB services is critical not only for emergency response, but also for long-term recovery. With many donors cutting back on aid, the Commission’s renewed support for the Global Fund sends a much-needed signal of leadership and solidarity.
Sidaction and Aidsfonds are pleased to jointly launch a call for scientific proposals for the year 2026, aimed at accelerating advances in HIV cure research.
The aim of this call for proposals is to fund research projects exploring mechanisms or strategies that will contribute to achieving a cure or remission for HIV. Projects may investigate mechanisms to target the viral reservoir or enhance immune-driven control, the development of new therapeutic concepts, as well as research in the social sciences related to HIV cure or remission.
Through this call, we aim to support research that will ultimately lead to major biomedical breakthroughs, foster social acceptance of cure interventions, and promote an HIV cure accessible to the largest possible number of people living with HIV worldwide.
